Imidazoquinoline Resiquimod (R-848)
Formula: C17H22N4O2 MW: 314.4 Immune response modifier. Potent antitumor and antiviral compound. Stimulates antibody secretion and cytokine production. Used as adjuvant to increase the effectiveness of vaccines, potent and selective synthetic ligand for Toll-like receptor 7 (TLR7) in mouse and for TLR7 and TLR8 in human Activates immune cells via the TLR7/TLR8 MyD88-dependent signaling pathway and leads to the induction of NF-kB, NLRP3/NALP3 inflammasome activator, independent of TLRs and RIG-I.Upregulator of the opioid growth factor receptor. Used in the treatment of skin lesions such as herpes simplex virus.
Product Specifications
Product Name Alternative
Resiquimod; S 28463; R848
Applications
Functional Assay
Purification
Purity >= 98%
Components
Liquid (1 mg/ml)
Storage Conditions
Store the product at 4°C for short term and at -20°C for long-term storage. Product is stable for 2 years at -20°C.
Applications Notes
Solubility: Soluble in DMSO, dichloromethane or methanol. Slightly soluble in acetonitrile or ethyl acetate.
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Major Vault Protein (MVP) (1032), CF488A conjugate, 0.1mg/mL
Tyrosinase (T311), CF568 conjugate, 0.1mg/mL
